Seminars in Oncology Nursing
Volume 23, Supplement 3 , Pages S15-S19, November 2007

Case Studies in the Treatment of Bladder Cancer

  • Gary Shelton

      Affiliations

    • Corresponding Author InformationAddress correspondence to Gary Shelton, MSN, ARNP, AOCN®, New York University Medical Center, 160 East 34th St, 11th Floor, NYU Cancer Institute, New York, NY 10016

Objectives

To illustrate the multiple factors that can influence the selection of treatments for bladder cancer, and to instruct the reader in the management of chemotherapy-related toxicities.

Data Sources

Actual cases drawn from the author's clinical experience and scientific studies.

Conclusion

Patients treated for bladder cancer often experience toxicities. Some patients being treated with novel agents may achieve stable disease.

Implications for Nursing Practice

Oncology nurses must be aware of and able to manage treatment-related toxicities with appropriate interventions. Patients can be effectively instructed in preventing and managing side effects, such as constipation, with the nurse's guidance.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(07)00096-4

doi:10.1016/j.soncn.2007.10.009

Seminars in Oncology Nursing
Volume 23, Supplement 3 , Pages S15-S19, November 2007